Organon & Co
XMUN:7XP
Organon & Co
XMUN:7XP
Price:
6.26
EUR
0.38%
Market Closed
Market Cap:
€1.6B
Balance Sheet
Balance Sheet Decomposition
Organon & Co
Organon & Co
Balance Sheet Decomposition is not available for
Organon & Co
Organon & Co
Balance Sheet
Organon & Co
Organon & Co
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
244
|
319
|
12
|
737
|
706
|
693
|
675
|
|
| Cash Equivalents |
244
|
319
|
12
|
737
|
706
|
693
|
675
|
|
| Total Receivables |
1 491
|
1 661
|
1 353
|
1 497
|
1 585
|
1 857
|
1 461
|
|
| Accounts Receivables |
1 491
|
1 474
|
1 038
|
1 382
|
1 475
|
1 744
|
1 358
|
|
| Other Receivables |
0
|
187
|
315
|
115
|
110
|
113
|
103
|
|
| Inventory |
994
|
1 071
|
913
|
915
|
1 003
|
1 315
|
1 321
|
|
| Other Current Assets |
985
|
904
|
1 289
|
611
|
637
|
643
|
891
|
|
| Total Current Assets |
3 714
|
3 955
|
3 567
|
3 760
|
3 931
|
4 508
|
4 348
|
|
| PP&E Net |
651
|
762
|
1 015
|
1 203
|
1 233
|
1 356
|
1 325
|
|
| PP&E Gross |
651
|
762
|
1 015
|
1 203
|
1 233
|
1 356
|
1 325
|
|
| Accumulated Depreciation |
621
|
676
|
820
|
882
|
902
|
1 017
|
1 060
|
|
| Intangible Assets |
812
|
569
|
503
|
651
|
649
|
533
|
1 414
|
|
| Goodwill |
4 603
|
4 603
|
4 603
|
4 603
|
4 603
|
4 603
|
4 680
|
|
| Other Long-Term Assets |
714
|
659
|
421
|
464
|
539
|
1 058
|
1 334
|
|
| Other Assets |
4 603
|
4 603
|
4 603
|
4 603
|
4 603
|
4 603
|
4 680
|
|
| Total Assets |
10 494
N/A
|
10 548
+1%
|
10 109
-4%
|
10 681
+6%
|
10 955
+3%
|
12 058
+10%
|
13 101
+9%
|
|
| Liabilities | ||||||||
| Accounts Payable |
289
|
258
|
259
|
1 382
|
1 132
|
1 314
|
1 153
|
|
| Accrued Liabilities |
819
|
807
|
659
|
1 021
|
1 188
|
1 389
|
1 411
|
|
| Short-Term Debt |
0
|
0
|
1 339
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
9
|
8
|
9
|
20
|
|
| Other Current Liabilities |
437
|
276
|
416
|
185
|
184
|
206
|
134
|
|
| Total Current Liabilities |
1 545
|
1 341
|
2 673
|
2 597
|
2 512
|
2 918
|
2 718
|
|
| Long-Term Debt |
34
|
70
|
0
|
9 125
|
8 905
|
8 751
|
8 860
|
|
| Deferred Income Tax |
149
|
139
|
128
|
4
|
19
|
47
|
74
|
|
| Other Liabilities |
2 418
|
1 963
|
1 822
|
463
|
411
|
412
|
977
|
|
| Total Liabilities |
4 146
N/A
|
3 513
-15%
|
4 623
+32%
|
12 189
+164%
|
11 847
-3%
|
12 128
+2%
|
12 629
+4%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
|
| Retained Earnings |
0
|
0
|
0
|
998
|
331
|
443
|
1 010
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
25
|
108
|
|
| Unrealized Security Profit/Loss |
7 256
|
7 949
|
6 108
|
0
|
0
|
0
|
0
|
|
| Other Equity |
908
|
914
|
622
|
513
|
564
|
541
|
649
|
|
| Total Equity |
6 348
N/A
|
7 035
+11%
|
5 486
-22%
|
1 508
N/A
|
892
+41%
|
70
+92%
|
472
N/A
|
|
| Total Liabilities & Equity |
10 494
N/A
|
10 548
+1%
|
10 109
-4%
|
10 681
+6%
|
10 955
+3%
|
12 058
+10%
|
13 101
+9%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
253
|
253
|
253
|
254
|
254
|
256
|
258
|
|
Switch to:
Switch to:
See Also
Discover More
